Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and …

T Chaiworapongsa, R Romero, SJ Korzeniewski… - American journal of …, 2013 - Elsevier
OBJECTIVE: To determine whether maternal plasma concentrations of placental growth
factor (PlGF), soluble endoglin (sEng), and soluble vascular endothelial growth factor
receptor-1 (sVEGFR-1) at 30-34 weeks of gestation can identify patients at risk for stillbirth,
late preeclampsia, and delivery of small-for-gestational-age (SGA) neonates. STUDY
DESIGN: A prospective cohort study included 1269 singleton pregnant women from whom
blood samples were obtained at 30-34 weeks of gestation and who delivered at> 34 weeks …